| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 8.370 | 34.945 | 59.602 | 74.232 | 72.015 | 101.008 | 104.573 | - |
| Total Income - EUR | - | 0 | 8.373 | 34.946 | 59.602 | 147.593 | 72.016 | 221.735 | 179.440 | - |
| Total Expenses - EUR | - | 5.071 | 44.503 | 42.245 | 81.616 | 72.129 | 48.716 | 79.133 | 98.008 | - |
| Gross Profit/Loss - EUR | - | -5.071 | -36.130 | -7.300 | -22.014 | 75.465 | 23.300 | 142.602 | 81.432 | - |
| Net Profit/Loss - EUR | - | -5.071 | -36.211 | -7.649 | -22.610 | 73.989 | 22.755 | 140.717 | 79.638 | - |
| Employees | - | 1 | 3 | 6 | 4 | 3 | 3 | 2 | 4 | - |
Check the financial reports for the company - Investigaţii Oftalmologice Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 2.759 | 4.025 | 3.702 | 3.005 | 1.936 | 1.067 | 544 | 422 | - |
| Current Assets | - | 797 | 19 | 7.099 | 6.955 | 32.793 | 36.298 | 173.372 | 256.987 | - |
| Inventories | - | 0 | 18 | 10 | 0 | 204 | 0 | 0 | 210 | - |
| Receivables | - | 0 | 0 | 1.997 | 4.071 | 318 | 3.464 | 172.938 | 255.971 | - |
| Cash | - | 797 | 1 | 5.092 | 2.884 | 32.271 | 32.834 | 433 | 805 | - |
| Shareholders Funds | - | -5.026 | -41.153 | -48.046 | -69.726 | 5.585 | 27.923 | 162.644 | 241.788 | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | 8.582 | 45.196 | 58.846 | 79.687 | 29.145 | 9.441 | 11.272 | 15.621 | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Investigaţii Oftalmologice Srl